A trial to test the effectiveness of a novel non-invasive treatment for fatty liver disease.
About this study
Eligible participants will be taking the investigational medication for a duration of 24 weeks and will need to return to the clinic every four (4) weeks for safety assessments. Participants will receive compensation for time and travel expenses.
This study is closed to recruitment.
Ethics
All research in Australia involving human participants is reviewed by an independent group called a Human Research Ethics Committee (HREC). The ethical aspects of this research study have been approved by the Royal Melbourne Hospital HREC.
This study is being carried out according to the National Statement on Ethical Conduct in Human Research (2007). This statement protects the interests of people who agree to participate in human research studies.
Level 2 South West
300 Grattan St, Parkville, Victoria